ClinicalTrials.gg
Enrolling by invitationNCT07265375Updated Sep 21, 2026

Cash Transfers for Reentry

An interventional study of Cash transfer in Poverty and Incarceration, sponsored by University of Pennsylvania. Enrolling by invitation at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-21.

Sponsored by University of Pennsylvania · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
450
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 26 studies in Recidivism with a site in United States — 3 open to participants now, 7 under way, 1 of them phase 3. Recidivism · United States.

Planned enrollment
9th of 25
450 · median 256
Started
2026
the only one that year
No phase
20 of 26
3 open now
Registered
26th of 26
by date

Among the 26 studies in Recidivism with a site in United States, this one is the 9th largest by planned enrollment of the 25 interventional ones that give a count, is the only one that started in 2026, is one of 20 with no phase, and was the 26th registered.

Recidivism

32 studies on the registry are indexed under Recidivism; 7 are open to participants now.

Browse Recidivism studies →

Open to participants now

3 of the 26 studies in Recidivism with a site in United States are open now. Recruiting first, the newest first:

All 3 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 4 Recidivism studies recruiting now, 3 set no upper age limit and 1 stops at 75 or younger; none take children under 18; none take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 26 studies in Recidivism with a site in United States, or all of them as a file.
02

Study summary

Investigators will execute a mixed methods randomized controlled trial to determine the impacts of cash transfers of $1,000 per month for one month followed by $750 for eleven months. Investigators will measure the impacts of the cash transfers on physical and mental health, housing stability, healthcare utilization, financial stability, and interactions with the criminal legal system.

Read the detailed description

The transition from incarceration to community reintegration represents a finite time period of unique challenges, often exacerbated by fines and other structural constraints associated with limited access to housing, the workforce, and public benefits. As such, individuals exiting prisons are most vulnerable for recidivism and other poor wellbeing outcomes during the initial period after their release.

The project will enroll approximately 200 individuals in the Omaha, NE area to receive cash transfers over a one year period. Another 250 will be assigned to the control group and will not receive the cash transfers but will be eligible to participate in research activities. Adults exiting Nebraska state prisons will be eligible to participate if they are exiting prison during the specified time frame and do not have a conviction of a sex crime or homicide.

Longitudinal repeated measures will be utilized through surveys conducted at baseline, 6 months, 12 months, and 18 month intervals. Future involvement with the criminal legal system will be measured using linked administrative data from the Department of Corrections. A select group of 30 participants across study groups will also be invited to participate in in-depth interviews with a CGIR research scientist and team at multiple time points.

03

Conditions studied

  • Poverty
  • Incarceration

Browse trials for

Keywords

  • cash transfer
  • incarceration
  • recidivism
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged 18 or older
  • Exiting Nebraska state prisons during the study enrollment period

Exclusion criteria

Exclusion criteria:

- Conviction of a sex crime or homicide

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
450 participants (estimated)

Study arms

  • Experimental
    Treatment

    Recipients of stipend

    Other: Cash transfer

  • No intervention
    Control

    No intervention

Interventions

  • OtherCash transfer

    Provision on monthly cash transfer

06

What researchers measure

Primary outcomes

  1. Recidivism

    As applied to adults, recidivism shall mean a final conviction of a Class I or II misdemeanor, a Class IV felony or above, or a Class W misdemeanor based on a violation of state law within 1 year of being successfully released.

    Time frame: 1 year following release date

  2. Post-release compliance with payment of fees

    Compliance/non-compliance with post-release payment of fees. A count of fee payments (continuous) and on-time payment as a binary outcome variable (y/n) for each instance.

    Time frame: 1 year post release date or for the duration of required supervision, whichever is sooner

  3. Post-release compliance with conditions

    Compliance/non-compliance with post-release conditions. A count of instances for each condition bounded by dates of conditions imposed.

    Time frame: 1 year post release date or for the duration of required supervision, whichever is sooner

Secondary outcomes

  1. Housing status

    Housing status (e.g., renter, homeowner, rent-to-own, etc.) reported in the prior month.

    Time frame: Baseline, 6 months, 12 months

  2. Food security (Household Food Insecurity Access Scale)

    9 items to assess past four week food insecurity: 1) worry about not having enough food, 2) inability to eat preferred foods, 3) eating a limited variety of foods, 4) having to eat foods that they did not want to eat, 5) eating a smaller meal than needed, 6) eating fewer meals in a day, 7) having no food to eat, 8) going to sleep at night hungry, and 9) going a whole day and night without eating. Items scored as "yes" (1) or "no" (0).

    Time frame: Baseline, 6 months, 12 months

  3. Employment

    Employment status as measured by one item with attributes per the U.S. Department of Labor.

    Time frame: Baseline, 6 months, 12 months

  4. Financial wellbeing (Consumer Financial Protection Bureau Financial Wellbeing Scale)

    Each item is scored 0 to 4 and summed to a total. The sum total is then converted to a total response value on the CFPB Financial Well-Being Scale score from 0-100, where higher scores indicate a greater sense of financial well-being.

    Time frame: Baseline, 6 months, 12 months

  5. Psychological distress (Kessler 6)

    Each item is scored from zero "none of the time" to four "all of the time." Scores of the 6 items are then summed, yielding a minimum score of 0 and a maximum score of 24. Low scores indicate low levels of psychological distress and high scores indicate high levels of psychological distress.

    Time frame: Baseline, 6 months, 12 months

  6. General health

    Self-reported general health as measured by one question from the SF-36: "In general, would you say your health is:", with a 5-point scale from Poor to Excellent.

    Time frame: Baseline, 6 months, 12 months

  7. Substance use (UNCOPE)

    Six items, each scored 0 (no) or 1 (yes). A score of two or more indicates possible substance misuse.

    Time frame: Baseline, 6 months, 12 months

07

Study locations

1 site
  • The Center for Guaranteed Income Research
    Philadelphia, Pennsylvania 19104, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2026 (actual). Primary completion is estimated for Dec 2028, 32 months after the start.

Of 20 interventional studies with no phase under Recidivism, half reached primary completion within 42 months of starting (the median), counting those still running; a quarter within 27 and three quarters within 65. This study's planned 32 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 17, 2025
First posted
Dec 4, 2025
StartActual
Apr 15, 2026
Primary completionEst.
Dec 15, 2028
CompletionEst.
Dec 15, 2029
Last update
Sep 21, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 21, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07265375
Responsible party
Sponsor
First posted
Dec 4, 2025
Start date
Apr 15, 2026
Primary completion
Dec 15, 2028 (estimated)
Completion
Dec 15, 2029 (estimated)
Last update
Sep 21, 2026

Study contacts

Stacia West, PhD
principal investigator · The University of Pennsylvania
Amy Castro, PhD
principal investigator · The University of Pennsylvania

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion